Chebore, Winnie
Zhou, Zhiyong
Westercamp, Nelli
Otieno, Kephas
Shi, Ya Ping
Sergent, Sheila B.
Rondini, Kelsey Anne
Svigel, Samaly Souza
Guyah, Benard
Udhayakumar, Venkatachalam
Halsey, Eric S.
Samuels, Aaron M.
Kariuki, Simon http://orcid.org/0000-0003-0554-1976
Funding for this research was provided by:
U.S. President's Malaria Initiative
Article History
Received: 27 May 2020
Accepted: 4 August 2020
First Online: 14 August 2020
Ethics approval and consent to participate
: The approval for the TES, which included testing of molecular markers for drug resistance, was obtained from the Kenya Medical Research Institute/Scientific and Ethics Review Unit (KEMRI/SERU). The U.S. Centers for Disease Control and Prevention Institutional Review Board approved reliance on the KEMRI/SERU for this protocol. Written informed consent was obtained from every parent or guardian of each participating child before enrolment.
: Not applicable.
: The authors declare that they have no competing interests.